David S. Winter and David J. Millstone's 40 North Management is one of the 749 hedge funds in our database that filed a 13F for the June 30 SEC reporting period.
Keep Reading →
November 5 - Hedge Fund Analysis, Hedge Funds, News
Andreas Halvorsen's Viking Global is one of the rare hedge funds that has a monstrous amount of capital in its equity portfolio (over $26 billion), yet holds it all in a relatively...
Keep Reading →
November 18 - Hedge Fund Analysis, Hedge Funds, News, Tech
Rail-Splitter Capital Management was founded in 2002 and is overseen by John Croghan and Richard Fradin.
Keep Reading →
August 10 - Hedge Fund Analysis, Hedge Funds, News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares reached as high as $83 per share in pre-market trading Monday, or over 18% higher than the stock’s closing price ...
Keep Reading →
July 27 - Hedge Funds, News
Carl Icahn is out with a new letter to Tim Cook arguing that Apple should buy back more shares and that the stock is grossly undervalued.
Keep Reading →
May 18 - Hedge Funds
The broad portfolio of Jacob Gottlieb’s Visium Asset Management enjoyed a very strong quarter, with the weighted average returns of its 817 reported positions in companies with...
Keep Reading →
April 10 - Hedge Funds, News
James E. Flynn's Deerfield Management is one of the funds that is focused on the healthcare sector, investing around 70% of its portfolio in healthcare stocks.
Keep Reading →
February 28 - Hedge Funds, News
The healthcare sector is one that has been performing very well in the short, but also medium and long-term.
Keep Reading →
February 24 - Hedge Funds, News
George Soros’ Soros Fund Management has opened a new position in Oclaro, Inc. (NASDAQ:OCLR). According to the 13G Form filed with the U.S.
Keep Reading →
February 24 - Hedge Funds, News
Farallon Capital, a hedge fund founded by Thomas Steyer in 1986, owns a pretty diversified portfolio, as its latest 13F filing showed.
Keep Reading →
February 23 - Hedge Funds, News
Pershing Square, managed by billionaire Bill Ackman, recently filed with the U.S.
Keep Reading →
February 19 - Hedge Funds, News
With the business of analyzing and compiling the data of our 737 tracked hedge funds’ latest 13F filings behind us, we’re ready to start sharing some of the findings from ...
Keep Reading →
February 19 - Hedge Fund Analysis, Hedge Funds, News
You may think that imitating the stock picks of billionaires will make you rich too. You need a reality check.
Keep Reading →
February 19 - Hedge Funds, News
The Insider Monkey data team is finally done processing nearly 750 13F filings and we will start sharing reports based on the aggregate hedge fund sentiment.
Keep Reading →
February 18 - Hedge Fund Analysis, Hedge Funds, News
Leon Cooperman's Omega Advisors has had a tough year, as overexposure to some energy stocks led to a 2.13% decline for the year.
Keep Reading →
February 18 - Hedge Funds, News
James E. Flynn’s Deerfield Management recently increased its stake in Auspex Pharmaceuticals Inc (NASDAQ:ASPX) by 1.5 million shares at $56.5 per share.
Keep Reading →
February 2 - Hedge Funds, News
eHealth, Inc.
Keep Reading →
January 22 - Hedge Funds, News
In a new filing with the U.S. Securities and Exchange Commission, OZ Management, a hedge fund managed by Daniel S.
Keep Reading →
January 20 - Hedge Funds, News
One of the sectors that has benefited from the highest returns over the years is Healthcare.
Keep Reading →
November 19 - Hedge Funds, News
Apple Inc. (NASDAQ:AAPL) has currently a market cap of about $671 billion.
Keep Reading →
November 18 - News, Tech
Last week, as it approached the end of the latest round of 13F filings, was pretty busy for experts at Insider Monkey, who have been gathering data and identifying the most popular...
Keep Reading →
November 17 - Hedge Funds, News
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) could lose out on a deal to acquire Botox Maker Allergan, Inc.
Keep Reading →
November 13 - News
As it was previously rumored in many sources, Bill Ackman's Pershing Square took a massive position in Zoetis Inc (NYSE:ZTS), as reported in a new filing with the US Securities...
Keep Reading →
November 12 - Hedge Funds, News
Bill Ackman's intentions to acquire Allergan, Inc.
Keep Reading →
November 7 - Hedge Funds, News
Bill Ackman may be failing all together on his push to get Allergan to agree to a merger agreement with Valeant Pharmaceuticals Intl Inc. (NYSE:VRX).
Keep Reading →
November 7 - News
The Madison Square Garden Company surprised many on Monday when it announced — besides exploring a potential breakup of itself — that it was adding two financiers to its board...
Keep Reading →
October 28 - Hedge Funds
Bill Ackman wants to clear up a few things.
Keep Reading →
October 24 - Hedge Funds
The best thing federal prosecutors might have done for Steven A.
Keep Reading →
October 16 - Hedge Funds
Jeffrey Ubben’s Valueact Capital Management disclosed today an increase in its exposure to Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
Keep Reading →
September 25 - Hedge Funds, News
Avenue Capital Group LLC, the U.S.
Keep Reading →
September 23 - Hedge Funds
Pershing Square, managed by Bill Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) have entered into an agreement with Allergan Inc.
Keep Reading →
September 17 - Hedge Funds, News
Hedge fund ESL Investments has loaned $400 million to its largest investment, Sears Holdings Corporation (NASDAQ:SHLD), a cash infusion that will keep the struggling retailer ...
Keep Reading →
September 16 - Hedge Funds
Minnesota Wild co-owner Phil Falcone might quit his hockey-crazed home state to make a play for the New York Islanders, The Post has learned.
Keep Reading →
September 15 - Hedge Funds
Bill Ackman does not show any signs of giving up on the proposed takeover of Allergan, Inc. (NYSE:AGN) by Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
Keep Reading →
September 10 - Hedge Funds, News
Hedge fund boss gives £5 million to build new museum maths gallery (Standard) A hedge fund manager who built his business on mathematical reasoning has given the Science Museum...
Keep Reading →
September 10 - Hedge Funds
40 North Management, managed by David S. Winter and David J. Millstone, recently filed its 13F with the U.S. Securities and Exchange Commission.
Keep Reading →
September 8 - Hedge Funds, News
CNBC's David Faber delivered the news that Allergan, Inc. (NYSE:AGN) is going to have a special shareholders' meeting on December 18th.
Keep Reading →
September 4 - Hedge Funds, News
David Einhorn's New York-based hedge fund firm Greenlight Capital missed August's market move altogether.
Keep Reading →
September 2 - Hedge Funds
Pavle Sabic, financial risk manager at S&P Capital IQ, in an interview on CNBC discussed the stocks that hedge funds have been most bulish on. The top company is Allergan Inc.
Keep Reading →
August 29 - Hedge Funds, News, Tech
In a new filing with the U.S.
Keep Reading →
August 28 - Hedge Funds, News
Manhattan US Attorney Preet Bharara has asked the Securities and Exchange Commission to hold off on its decision about former hedge-fund kingpin Steve Cohen for three more months...
Keep Reading →
August 27 - Hedge Funds
When William Ackman took the stage at the AXA Equitable Auditorium in Midtown Manhattan on April 22, investors were still digesting the news that his firm, Pershing Square Capital...
Keep Reading →
August 22 - Hedge Funds
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Bill Ackman’s Pershing Square Capital Management will today comply with one of Allergan, Inc.
Keep Reading →
August 22 - Hedge Funds, News
Having lost all his savings on Black Monday in 1987, James Dinan made a remarkable comeback, setting up his hedge fund, York Capital Management, in 1991 with $3.6 million and...
Keep Reading →
August 22 - Hedge Funds, News
Stephen Mandel’s Lone Pine Capital has revealed for the second quarter a portfolio of 67 companies worth $24.7 billion.
Keep Reading →
August 20 - Hedge Funds, News
In its latest 13F filing with the U.S.
Keep Reading →
August 18 - Hedge Funds, News
Allergan, Inc. (NYSE:AGN)'s stock saw a massive upside in April when it was revealed that Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was trying to buy the company with the...
Keep Reading →
August 15 - Hedge Funds, News
Jeffrey Ubben’s ValueAct Capital has disclosed its holdings for the second quarter, revealing 16 investments which have a current market value of $13.5 billion.
Keep Reading →
August 15 - Hedge Funds, News
Speaking to CNBC’s Scott Wapner over the phone yesterday, investor and hedge fund manager Bill Ackman denied the allegations set forth against him and Valeant Pharmaceuticals...
Keep Reading →
August 15 - Hedge Funds, News